Recently, we disclosed the remarkable potential of a damaged TME in conferring resistance to cancer cells that survive anticancer therapies, as exemplified by the SASP factors including WNT16B and SFRP2 (Sun et al., 2012, 2016). Here, SFRP2 is linked to cancer.